"Fresh Human Kidney Tissue: Exploring biomarkers and intervention targets in chronic kidney disease"
The FRIGG project (2021-2023) aimed establish a human-based model for chronic kidney disease based on fresh human kidney tissue obtained directly from patients. This human model can be used in the lab to mimic development and progression of some of the key processes in chronic kidney disease.
The human model system developed by the FRIGG team will give researchers a better starting point for identifying potential drug targets. More importantly, a human model system will also increase translatability between the laboratory and patients. The FRIGG team included three different companies and several academic researchers. Combined, the team spanned expertise in renal disease, renal physiology, advanced bioimaging and methods for gene expression and biomarker identification.
On this page you can can watch a video recorded at the beginning of the FRIGG project and find a list of project participants. You can also read a full article about the project or read a very short cartoon introduction to the project.
THE FRIGG TEAM
Academic team members
- Rikke Nørregaard, Professor, Aarhus University
- Lene Niemann Nejsum, Professor, Aarhus University
- Lin Lin, Assoc. Professor, Aarhus University
- Henricus A. M. Mutsaers, Asst. Professor, Aarhus University
- Mia Gebauer Madsen, Chief Physician, Aarhus University Hospital
- Anna Krarup Keller, Assoc. Professor, Aarhus University Hospital
- Gitte Albinus Pedesen, postdoc, Aarhus University
- Camilla Merrild, PhD student, Aarhus University
- Jørgen Kjems, Professor, Aarhus University
Industrial team member
- Pernille Lærkegaard Hansen, AstraZeneca
- Shrikant R. Mulay, AstraZeneca
- Lihuan Liang, AstraZeneca
- Federica Genovesa, Nordic Bioscience
- Alexandra Louise Møller
- Agnès Bèrnadeau, Novo Nordisk
- Peter Helding Kvist, Novo Nordisk
- Maria Ougaard, Novo Nordisk
ABOUT ODIN
We unite bright minds from industry and academia to jointly create need-driven clinical research projects - and pave the way for innovative new treatments and diagnostics. We fund the best project ideas through competitive funding calls. Although companies cannot receive funding, it is free of charge to join.
The platform is sponsored by the Novo Nordisk Foundation with 180 million DKK from 2024-2029.
CONTACT ODIN
You are welcome to contact us if you have questions or comments. Reach out to odin@au.dk or find the Secretariat's direct email addresses under contacts.
Although the platform spans five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 120, blg 1521-214.
